MedTrace Logo

Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities

NCT01302210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22302

Last updated 2019-09-11

No results posted yet for this study

Summary

Our hypothesis for the DERAIL MRSA program is that one can safely remove the colonization risk from nearly all residents (patients) in a way that does not interfere with the desired life-style for persons in these facilities and thereby reduce the risk of infection and lower the cost of care by avoiding preventable disease.

Conditions

  • Methicillin Resistant Staphylococcus Aureus

Interventions

DRUG

Decolonization

5 day regimen of mupirocin calcium 2% twice daily to the nares and any open wound plus bath or shower with 4% chlorhexidine used as a liquid soap

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Endeavor Health

    lead OTHER

Principal Investigators

  • Lance R Peterson, MD · Endeavor Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-12-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302210 on ClinicalTrials.gov